Adjuvant radiotherapy omission in early breast cancer: the PROSPECT trial - Authors' reply

Affiliations

¹ The Royal Melbourne Hospital, Melbourne 3050, VIC, Australia. Electronic address: bruce.mann@mh.org.au.
² The Royal Melbourne Hospital, Melbourne 3050, VIC, Australia.
³ Breast Cancer Trials, Newcastle, NSW, Australia.

Comment

Gregory Bruce Mann et al. Lancet. 2024.

. 2024 Aug 10;404(10452):526.

doi: 10.1016/S0140-6736(24)01362-X.

¹ The Royal Melbourne Hospital, Melbourne 3050, VIC, Australia. Electronic address: bruce.mann@mh.org.au.
² The Royal Melbourne Hospital, Melbourne 3050, VIC, Australia.
³ Breast Cancer Trials, Newcastle, NSW, Australia.

No abstract available

Comment on

Adjuvant radiotherapy omission in early breast cancer: the PROSPECT trial.
Mo DC, Huang JF, Luo PH, Wang HL, Liang XJ. Mo DC, et al. Lancet. 2024 Aug 10;404(10452):524-525. doi: 10.1016/S0140-6736(24)01359-X. Lancet. 2024. PMID: 39127475 No abstract available.
Adjuvant radiotherapy omission in early breast cancer: the PROSPECT trial.
Swanick CW, Kelly P, Dvorak T, Mamounas EP. Swanick CW, et al. Lancet. 2024 Aug 10;404(10452):525-526. doi: 10.1016/S0140-6736(24)01360-6. Lancet. 2024. PMID: 39127477 No abstract available.
Adjuvant radiotherapy omission in early breast cancer: the PROSPECT trial.
Kunkler I, Cameron D, Dixon M, Williams L. Kunkler I, et al. Lancet. 2024 Aug 10;404(10452):525. doi: 10.1016/S0140-6736(24)01361-8. Lancet. 2024. PMID: 39127478 No abstract available.